# Oral Omadacycline vs. Oral Nitrofurantoin for the Treatment of Cystitis

> **NCT03425396** · PHASE2 · COMPLETED · sponsor: **Paratek Pharmaceuticals Inc** · enrollment: 225 (actual)

## Conditions studied

- Uncomplicated Urinary Tract Infection
- Cystitis

## Interventions

- **DRUG:** Omadacycline tablets
- **DRUG:** Nitrofurantoin capsules

## Key facts

- **NCT ID:** NCT03425396
- **Lead sponsor:** Paratek Pharmaceuticals Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-04
- **Primary completion:** 2019-05-15
- **Final completion:** 2019-06-05
- **Target enrollment:** 225 (ACTUAL)
- **Last updated:** 2020-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03425396

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03425396, "Oral Omadacycline vs. Oral Nitrofurantoin for the Treatment of Cystitis". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03425396. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*